| Stephanie Misono, MD | |
|
909 Fulton St Se, Minneapolis, MN 55455-4800 | |
| (612) 626-5900 | |
| (612) 625-2101 |
| Full Name | Stephanie Misono |
|---|---|
| Gender | Female |
| Speciality | Otolaryngology |
| Experience | 20 Years |
| Location | 909 Fulton St Se, Minneapolis, Minnesota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578673398 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | ML20008113 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Minnesota Medical Center, Fairview | Minneapolis, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Fairview Express Care | 3375645179 | 1523 |
| University Of Minnesota Health Clinics And Surgery Center Inc | 9133423304 | 492 |
News Archive
In Virginia, Democratic lawmakers are pushing a proposal to establish a state-based exchange. These legislators see their plan, which is built on the argument that state action would keep the federal government from being involved, will draw support from others regardless of their feelings about the health law itself. Meanwhile, Montana's high-risk insurance pool is running out of cash.
Neurelis, Inc. today announced the completion of subject dosing in a randomized crossover study assessing diazepam pharmacokinetics and bioavailability after administration of two proprietary formulations of intranasal diazepam and intravenous injection.
ARCA biopharma, Inc., a biopharmaceutical company developing genetically targeted therapies for heart failure and other cardiovascular diseases, today announced that during the first quarter of 2010, through its previously established equity distribution agreement, it raised net proceeds of approximately $6.8 million through the sale of 1,075,000 shares of ARCA common stock in open market.
Bionovo Inc. today announced the publication of results from a study demonstrating the three distinct classes of genes regulated by estrogen receptor beta. The results are published in the Journal of Biological Chemistry. This is an important discovery for future development of selective drugs regulating this pathway.
A $75 million Department of Defense grant to improve technologies to treat soldiers injured on the battlefield and advance care for the public will involve bioengineers at Rice University and the University of Texas Health Science Center at Houston.
› Verified 5 days ago
| Entity Name | University Of Minnesota Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477598118 PECOS PAC ID: 9830001189 Enrollment ID: O20031104000532 |
News Archive
In Virginia, Democratic lawmakers are pushing a proposal to establish a state-based exchange. These legislators see their plan, which is built on the argument that state action would keep the federal government from being involved, will draw support from others regardless of their feelings about the health law itself. Meanwhile, Montana's high-risk insurance pool is running out of cash.
Neurelis, Inc. today announced the completion of subject dosing in a randomized crossover study assessing diazepam pharmacokinetics and bioavailability after administration of two proprietary formulations of intranasal diazepam and intravenous injection.
ARCA biopharma, Inc., a biopharmaceutical company developing genetically targeted therapies for heart failure and other cardiovascular diseases, today announced that during the first quarter of 2010, through its previously established equity distribution agreement, it raised net proceeds of approximately $6.8 million through the sale of 1,075,000 shares of ARCA common stock in open market.
Bionovo Inc. today announced the publication of results from a study demonstrating the three distinct classes of genes regulated by estrogen receptor beta. The results are published in the Journal of Biological Chemistry. This is an important discovery for future development of selective drugs regulating this pathway.
A $75 million Department of Defense grant to improve technologies to treat soldiers injured on the battlefield and advance care for the public will involve bioengineers at Rice University and the University of Texas Health Science Center at Houston.
› Verified 5 days ago
| Entity Name | Fairview Express Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053952606 PECOS PAC ID: 3375645179 Enrollment ID: O20081028000548 |
News Archive
In Virginia, Democratic lawmakers are pushing a proposal to establish a state-based exchange. These legislators see their plan, which is built on the argument that state action would keep the federal government from being involved, will draw support from others regardless of their feelings about the health law itself. Meanwhile, Montana's high-risk insurance pool is running out of cash.
Neurelis, Inc. today announced the completion of subject dosing in a randomized crossover study assessing diazepam pharmacokinetics and bioavailability after administration of two proprietary formulations of intranasal diazepam and intravenous injection.
ARCA biopharma, Inc., a biopharmaceutical company developing genetically targeted therapies for heart failure and other cardiovascular diseases, today announced that during the first quarter of 2010, through its previously established equity distribution agreement, it raised net proceeds of approximately $6.8 million through the sale of 1,075,000 shares of ARCA common stock in open market.
Bionovo Inc. today announced the publication of results from a study demonstrating the three distinct classes of genes regulated by estrogen receptor beta. The results are published in the Journal of Biological Chemistry. This is an important discovery for future development of selective drugs regulating this pathway.
A $75 million Department of Defense grant to improve technologies to treat soldiers injured on the battlefield and advance care for the public will involve bioengineers at Rice University and the University of Texas Health Science Center at Houston.
› Verified 5 days ago
| Entity Name | University Of Minnesota Health Clinics And Surgery Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053795187 PECOS PAC ID: 9133423304 Enrollment ID: O20160209000524 |
News Archive
In Virginia, Democratic lawmakers are pushing a proposal to establish a state-based exchange. These legislators see their plan, which is built on the argument that state action would keep the federal government from being involved, will draw support from others regardless of their feelings about the health law itself. Meanwhile, Montana's high-risk insurance pool is running out of cash.
Neurelis, Inc. today announced the completion of subject dosing in a randomized crossover study assessing diazepam pharmacokinetics and bioavailability after administration of two proprietary formulations of intranasal diazepam and intravenous injection.
ARCA biopharma, Inc., a biopharmaceutical company developing genetically targeted therapies for heart failure and other cardiovascular diseases, today announced that during the first quarter of 2010, through its previously established equity distribution agreement, it raised net proceeds of approximately $6.8 million through the sale of 1,075,000 shares of ARCA common stock in open market.
Bionovo Inc. today announced the publication of results from a study demonstrating the three distinct classes of genes regulated by estrogen receptor beta. The results are published in the Journal of Biological Chemistry. This is an important discovery for future development of selective drugs regulating this pathway.
A $75 million Department of Defense grant to improve technologies to treat soldiers injured on the battlefield and advance care for the public will involve bioengineers at Rice University and the University of Texas Health Science Center at Houston.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Stephanie Misono, MD 420 Delaware Street Se, Mmc 396, Minneapolis, MN 55455 Ph: (612) 626-5900 | Stephanie Misono, MD 909 Fulton St Se, Minneapolis, MN 55455-4800 Ph: (612) 626-5900 |
News Archive
In Virginia, Democratic lawmakers are pushing a proposal to establish a state-based exchange. These legislators see their plan, which is built on the argument that state action would keep the federal government from being involved, will draw support from others regardless of their feelings about the health law itself. Meanwhile, Montana's high-risk insurance pool is running out of cash.
Neurelis, Inc. today announced the completion of subject dosing in a randomized crossover study assessing diazepam pharmacokinetics and bioavailability after administration of two proprietary formulations of intranasal diazepam and intravenous injection.
ARCA biopharma, Inc., a biopharmaceutical company developing genetically targeted therapies for heart failure and other cardiovascular diseases, today announced that during the first quarter of 2010, through its previously established equity distribution agreement, it raised net proceeds of approximately $6.8 million through the sale of 1,075,000 shares of ARCA common stock in open market.
Bionovo Inc. today announced the publication of results from a study demonstrating the three distinct classes of genes regulated by estrogen receptor beta. The results are published in the Journal of Biological Chemistry. This is an important discovery for future development of selective drugs regulating this pathway.
A $75 million Department of Defense grant to improve technologies to treat soldiers injured on the battlefield and advance care for the public will involve bioengineers at Rice University and the University of Texas Health Science Center at Houston.
› Verified 5 days ago
Jeffrey C. Manlove, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2211 Park Ave, Minneapolis, MN 55404 Phone: 612-871-1144 Fax: 612-871-2012 | |
Richard M. Levinson, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 2211 Park Ave, Minneapolis, MN 55404 Phone: 612-871-1144 Fax: 612-871-2012 | |
Robert H Maisel, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 701 Park Ave, P7, Minneapolis, MN 55415 Phone: 612-873-2424 | |
Sivakumar Chinnadurai, MD, MPH Otolaryngology Medicare: Medicare Enrolled Practice Location: 2530 Chicago Ave Ste 450, Minneapolis, MN 55404 Phone: 615-813-6000 | |
Samir Suresh Khariwala, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 516 Delaware St Se, Clinic 8a, Minneapolis, MN 55455 Phone: 612-625-7400 | |
Tina Chung-ting Huang, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 420 Delaware St Se, University Of Minnesota Physicians, Minneapolis, MN 55455 Phone: 612-626-5900 | |
Carrie E Flanagan, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 420 Delaware St Se, Mmc 293, Minneapolis, MN 55455 Phone: 612-625-7634 |